// App-Quantinova.ai

: AKT1/AKT2 mRNA Balance Is Significantly Different In IPF BAL Cells Compared To Other Fibrotic ILDs.

Researchers

Presenter

  • E Tsitoura

Principal Investigators

  • E Bibaki

  • E Vasarmidi

  • C Koutoulaki

  • G Margaritopoulos

  • K Karagiannis

  • A Proklou

  • A Trachalaki

  • D Moraitaki

  • N Tzanakis

  • A Wells

  • K Antoniou

Medical Centers

  • Heraklion, Greece, Laboratory of Molecular and Cellular Pulmonology, Medical School, University of Crete

  • Heraklion, Greece, Department of Thoracic Medicine, Interstitial Lung Disease Unit, University Hospital

  • London, United Kingdom, Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College

Locations

  • Greece

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Pulmonary fibrosis

Biomarkers

  • microRNA-155

  • AKT Serine

  • AKT Serine/Threonine Kinase 2

  • Cluster of Differentiation 11c

  • Cluster of Differentiation 163

  • Cluster of differentiation 45

Drug/Treatment

  • miR155

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved